SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001657312-19-000013
Filing Date
2019-03-26
Accepted
2019-03-26 07:01:46
Documents
5
Period of Report
2019-03-26

Document Format Files

Seq Description Document Type Size
1 6-K a20190320pdmrpmnoticemarch.htm 6-K 28844
2 EXHIBIT 1.1 a20190320pdmrnotice20march.htm EX-1.1 26714
3 EXHIBIT 1.2 a20190325pdmrnotice25march.htm EX-1.2 26918
4 EXHIBIT 1.3 a20190325agmnotice19exhibit.htm EX-1.3 13402
5 verona3may2018agmresu_image1.gif GRAPHIC 4114
  Complete submission text file 0001657312-19-000013.txt   102682
Mailing Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE
Business Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE 011-44-0-2032834200
Verona Pharma plc (Filer) CIK: 0001657312 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38067 | Film No.: 19704065
SIC: 2834 Pharmaceutical Preparations